Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Drug Safety|September 27, 2014
Safety profile of biological medicines as compared with non-biologicals: an analysis of the italian spontaneous reporting system databasePaola M Cutroneo, Valentina Isgrò, Alessandra Russo, et al.
Aging Clinical and Experimental Research|April 7, 2025
Safety of direct oral anticoagulants reversal agents in older patients: an analysis of individual case safety reports of adverse drug reaction from VigiBase®Giada Crescioli, Niccolò Lombardi, Elena Arzenton, et al.
European Journal of Clinical Pharmacology|March 6, 2014
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluationFrancesco Salvo, Emanuel Raschi, Ugo Moretti, et al.
Frontiers in Drug Safety and Regulation|September 22, 2025
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systemsPaola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Drug Safety|May 9, 2024
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance DatabaseRenato de Filippis, John M Kane, Elena Arzenton, et al.
Drug Safety|June 1, 2005
Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance databaseRoberto Leone, Anita Conforti, Mauro Venegoni, et al.
Plos One|November 27, 2013
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across EuropeEmanuel Raschi, Elisabetta Poluzzi, Brian Godman, et al.
Drug Safety|November 18, 2022
Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting DatabaseChiara Gastaldon, Georgios Schoretsanitis, Elena Arzenton, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 12, 2020
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systemsMilo Gatti, Ilaria Ippoliti, Elisabetta Poluzzi, et al.
Pharmacogenetics and Genomics|November 7, 2015
CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control studyAdolfo Figueiras, Ana Estany-Gestal, Carmelo Aguirre, et al.
Pageof 8